Industries > Pharma > Global Precision Medicine Market Forecast 2019-2029

Global Precision Medicine Market Forecast 2019-2029

Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases

PUBLISHED: 30 May 2019
PAGES: 212
PRODUCT CODE: PHA0424

Clear
WOOCS 2.2.1

The global precision medicine market is expected to grow at an estimated CAGR of 10.5% from 2018 to 2029. In the precision medicine market, the Diagnostic Tool companies’ segment is dominating the global market and accounted for $23.36 billion in 2018 due to the development of large number of diagnostic and genetic tests.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 212-page report you will receive 98 tables and 63 figures– all unavailable elsewhere.

The 212-page report provides clear detailed insight into the global precision medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Precision Medicine Market forecasts from 2019-2029

• Along with revenue prediction for the overall market for the global precision medicine market, our investigation shows forecasts to 2029 for the market segmented by technology:
– Companion Diagnostics
– Biomarker-based Test
– Targeted Therapeutics
– Pharmacogenomics
– Molecular Diagnostics

The report discusses key trends, developments and participants.

• This report breaks down the precision medicine market forecast to 2029 by end-users:
– Pharmaceuticals & Biotechnology Companies
– Diagnostic Companies
– Healthcare IT/Big Data Companies
– Clinical Laboratories

The report discusses key trends, developments and participants.

• This report also breaks down the precision medicine market forecast to 2029 by therapeutic application:
– Cancer
– Cardiovascular Diseases
– Central Nervous System
– Infectious Diseases
– Immunology
– Others

The report discusses key trends, developments and participants.

• This study provides precision medicine market forecasts to 2029 for these regional markets:
– North America: US & Canada
– Europe: Germany, UK, France, Italy, Spain, Rest of Europe
– Asia-Pacific: China, japan, India, Australia, South Korea, Rest of Asia-Pacific
– Middle East & Africa: South Africa, Saudi Arabia, Rest of Middle East & Africa
– Latin America: Brazil, Mexico, Rest of Latin America

For each regional market, the report discusses key trends, developments and participants.

• This report profiles selected leading companies that are the main players in the global precision medicine market:
– Abbott
– Danaher Corporation
– GE Healthcare
– GlaxoSmithKline
– Illumina, Inc.
– Johnson & Johnson
– Laboratory Corporation of America Holdings
– Novartis
– Pfizer
– QIAGEN
– Thermo Fisher Scientific, Inc.

Global Precision Medicine Market Forecast 2019-2029

• Our study discusses the drivers, restraints as well as the opportunities in the global precision medicine market.

• This study also analyzed the global precision medicine market with Porter’s Five Forces Analysis as well as Value Chain Analysis

• This report discusses selected market developments in the precision medicine market: partnership, collaboration, join venture, acquisitions, product launch, product development, expansions, patents, approvals.

Visiongain’s study is intended for anyone requiring commercial analyses for the global precision medicine market. You find data, trends and predictions.

Buy our report today Global Precision Medicine Market Forecast 2019-2029: Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Precision Medicine Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Precision Medicine Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

READ

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

READ

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

READ

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

READ

Categories

Category